- Directions for use
- Sincerus Florida, LLC. Adverse reactions
- Active, inactive
- NDC 72934-4054-3 CLINDAMYCIN USP 1% / NIACINAMIDEUSP 4% / TRETINOIN USP 0.05%. Solution 60gm
-
INGREDIENTS AND APPEARANCE
CLINDAMYCIN 1% / NIACINAMIDE 4% / TRETINOIN 0.05%
clindamycin 1% / niacinamide 4% / tretinoin 0.05% solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-4054 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CLINDAMYCIN PHOSPHATE (UNII: EH6D7113I8) (CLINDAMYCIN - UNII:3U02EL437C) CLINDAMYCIN PHOSPHATE 1 g in 100 g NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 4 g in 100 g TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R) TRETINOIN 0.05 g in 100 g Product Characteristics Color yellow Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-4054-3 60 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/07/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/07/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-4054)